Evidence map›Paper›PMID 41359284›Full record

ArticleThe protein journal2026

Expression and Purification of p70 (∆NH

Shafat A Latoo

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shafat A LatooDepartment of Biochemistry, Cluster University, M. A. Road, Srinagar, Jammu and Kashmir, 190001, India. shafat1s@yahoo.co.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An essential modulator of cell growth and division is the evolutionarily conserved kinase (S6K1). It is triggered by certain stimulants, including amino acids, insulin, and other growth hormones. The Akt/phosphatidylinositol 3-kinase pathway's downstream effector, the serine/threonine kinase S6K1, is consistently activated in a variety of cancer types. Rho family guanosine triphosphate (GTPase) activation and actin filament cross-linking are two of S6K1's roles. The p70 (∆2-146/∆CT104) S6K is a truncated variant of p70S6 kinase, created by removing 146 amino acids from the N-terminal and 104 amino acids from the C-terminal end of the original protein, resulting in a total of 275 amino acids. The p70 (∆2-146/∆CT104) S6K was effectively expressed in the E. coli BL21 (DE3)pLysS strain after being cloned in E. coli DH5α. A rabbit polyclonal anti-GST antibody had been employed during Western blot analysis throughout the protein's production and purification process. Protein purification was achieved by affinity chromatography using glutathione resin-agarose beads, and chromatography onto a spin concentration column was performed. Rabbit polyclonal anti-(p70S6Kinase and GST) antibodies confirmed the presence of the purified protein.

Indexed as

Escherichia coliGlutathione TransferaseRecombinant Fusion ProteinsRibosomal Protein S6 Kinases, 70-kDaAnimalsCloning, MolecularGene ExpressionRabbitsGlutathione TransferaseRecombinant Fusion ProteinsRibosomal Protein S6 Kinases, 70-kDaActinAuto inhibitory domainGlutathionep70S6 kinase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.